Latest Morning Briefing Stories
Top California Democrats Clash Over How To Rein In Drug Industry Middlemen
Frustrated by spiraling drug costs, California lawmakers want to increase oversight of pharmaceutical industry intermediaries known as pharmacy benefit managers. It’s unclear whether they can persuade Gov. Gavin Newsom to get on board.
Long-Covid Patients Are Frustrated That Federal Research Hasn’t Found New Treatments
The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market. Patients and scientists say it’s time to push harder for breakthroughs.
Health Care Is Newsom’s Biggest Unfinished Project. Trump Complicates That Task.
As Gov. Gavin Newsom enters the second half of his final term, health care stands out as his most ambitious but glaringly incomplete initiative for California residents. The issue will likely shape his national profile for better or worse. And now, Donald Trump brings a new wrinkle.
La salud, un proyecto inconcluso del gobernador de California
Algunas de las iniciativas emblemáticas de Newsom en materia de salud, que podrían definir su perfil en el escenario nacional, están en peligro con el regreso de Donald Trump a la Casa Blanca.
‘Bill of the Month’: The Series That Dissects and Slashes Medical Bills
Since 2018, readers and listeners sent KFF Health News-NPR’s “Bill of the Month” thousands of questionable bills. Our crowdsourced investigation paved the way for landmark legislation and highlighted cost-saving strategies for all patients.
Employers Press Congress To Cement Health Price Transparency Before Trump’s Return
Donald Trump’s first administration advanced rules forcing hospitals and insurers to reveal prices for medical services. Employers don’t want to risk backtracking during Trump’s second administration.
Readers Offer ‘Solo Agers’ Support and Reflect on Ancestors
KFF Health News gives readers a chance to comment on a recent batch of stories.
How a Duty To Spend Wisely on Worker Benefits Could Loosen PBMs’ Grip on Drug Prices
As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” PBMs — or force them to change.
Rage Has Long Shadowed American Health Care. It’s Rarely Produced Big Change.
The outpouring of anger at health insurers following the killing of UnitedHealthcare CEO Brian Thompson continues a cycle of rage that dates back decades.
Florida’s Canada Drug Importation Plan Has Yet to Launch
Florida Gov. Ron DeSantis (R) spent years complaining that the Biden administration was slow-walking federal approval of his plan to import lower-cost prescription drugs from Canada — a concept endorsed by Donald Trump in 2020 just before his first presidential term ended. But nearly a year since the Food and Drug Administration green-lit the state’s […]
Who Gets Obesity Drugs Covered by Insurance? In North Carolina, It Helps If You’re on Medicaid
GLP-1 agonist medications such as Ozempic accounted for 10% of the North Carolina state employee health plan’s prescription drug spending, so the state is no longer covering them for weight loss alone. Still, it did decide to cover them for Medicaid patients’ weight loss. A look inside the state’s coverage calculus.
¿Podrían los nuevos medicamentos para bajar de peso estar disponibles para todos?
Los medicamentos agonistas GLP-1, conocidos por los nombres comerciales Ozempic, Trulicity y Wegovy, han demostrado ser efectivos para la pérdida de peso y para el manejo de la diabetes tipo 2.
Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval
Florida sued the FDA over what it said was a “reckless delay” in approving its drug importation plan. Now, nearly a year after the FDA gave the state the green light, the program has yet to begin.
El plan del gobernador de Florida para importar medicamentos más baratos de Canadá sigue en la nada
Florida solicitó crear un programa de importación en noviembre de 2020, pocos meses después que la administración Trump concediera esta opción a los estados.
Listen: A Tussle With a Rattlesnake Can Take a Bite Out of Your Wallet
Listen to KFF Health News’ Jackie Fortiér recount how a backyard snakebite led to a harrowing hospitalization — and big bills — for a San Diego family.
No Evidence Trump’s Drug Program for Terminal Patients Saved ‘Thousands’ of Lives
Though the former president has repeatedly hyped the impact of his experimental drug program, there’s no basis for his claims in government data, and medical experts say he’s exaggerating.
What’s at Stake: A Pivotal Election for Six Big Health Issues
Health care has ebbed and surged as an election issue throughout the presidential campaign. Here are the ways some of the most consequential changes in health policies could hinge on whether Vice President Kamala Harris or former President Donald Trump wins.
Beneficiarios de Medicare gastarán menos en medicamentos en 2025
El período de inscripción anual para que los beneficiarios de Medicare renueven o cambien su cobertura de medicamentos, o elijan un plan Medicare Advantage, comenzó el 15 de octubre y se extiende hasta el 7 de diciembre.
Medicare Drug Plans Are Getting Better Next Year. Some Will Also Cost More.
Every year, Medicare officials encourage beneficiaries to shop around for their drug coverage. Few take the time. This year, it might be more important than ever.
Journalists Address Opioid Settlements, Undiagnosed ADHD, and a Georgia Chemical Fire
KFF Health News and California Healthline staff made the rounds on national and local media in the last two weeks to discuss topical stories. Here’s a collection of their appearances.
